Meihao Medical Group Co., Ltd.

Meihao Medical Group Co., Ltd.

1947.HK
Meihao Medical Group Co., Ltd.HK flagHong Kong Stock Exchange
0.54
HKD
- -
- -
324.08MMarket Cap
Meihao Medical Group Co., Ltd.
1947.HK
(Hong Kong Stock Exchange)

Recent

price

0.54

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
FRC
0.14
0.14
0.18
0.28
0.12
0.13
- -
Revenue per Share
0.03
0.02
0.05
0.06
-0.02
-0.06
- -
Basic EPS, GAAP
0.03
0.04
0.05
0.05
- -
-0.03
- -
Free Cash Flow per Basic Share
0.02
0.03
- -
- -
- -
0.01
- -
Dividend per Share
- -
- -
- -
0.12
0.07
- -
- -
Book Value per Share
0.03
0.03
0.08
0.39
0.28
0.19
- -
Tangible Book Value per Share
600
600
600
457
600
582
- -
Basic Weighted Avg Shares
83
85
105
127
74
75
102
Sales/Revenue/Turnover
28.9
30.65
42.23
32.38
-14.75
-43.75
-20.05
Operating Margin (%)
7
8
11
13
14
14
15
Depreciation Expense
15
15
32
28
-14
-32
-14
Net Income, GAAP
33.01
38.08
26.31
28.93
- -
- -
- -
Effective Tax Rate (%)
18.55
17.63
30.45
22.33
-18.49
-43.42
-14.1
Profit Margin (%)
-6
-4
8
135
114
58
54
Working Capital
15
13
35
30
25
25
10
LT Debt
20
18
51
178
166
120
107
Total Equity
- -
26.05
36.9
17.82
- -
- -
- -
Return on Invested Capital (%)
- -
47.82
73.89
44.07
- -
- -
- -
Return on Capital (%)
- -
- -
- -
107.56
-29.48
-159.08
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
76.33%
-11.07%
Free Cash Flow
- -
-7,917.6%
-130.26%
Net Income, GAAP
- -
7.78%
-55.77%
Sales/Revenue/Turnover
- -
8.2%
36.16%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
74
2024
- -
- -
- -
- -
75
2025
- -
- -
- -
- -
102

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.02
2024
- -
- -
- -
- -
-0.06
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
- -
Business
Meihao Medical Group Co., Ltd. is a medical services company that operates a network of private dental hospitals and clinics in China, focusing on general, reparative, implant, and orthodontic/cosmetic dentistry. The group provides a comprehensive range of dental services through its branded hospital network and related dental facilities, with an emphasis on patient-centered oral healthcare delivery across its regional footprint in Zhejiang and other locations in China. The company is headquartered in Hong Kong with operations anchored in Wenzhou, Zhejiang, and expanded facilities across multiple cities, including Rui’an and Longgang, as part of its growth strategy to broaden access to specialized dental care. Core products and services - General dentistry: comprehensive oral examinations, preventive care, routine restorative procedures, preventive dentistry, and general dental treatments. - Reparative dentistry: restorative dentistry, crowns, bridges, fillings, and other tooth-rehabilitation procedures. - Implant dentistry: dental implants, implant-supported restorations, surgical placement, and prosthetic integration. - Orthodontics and cosmetic dentistry: braces, aligners, occlusal corrections, cosmetic dental procedures, and aesthetic smile enhancements. - Pediatric dentistry: child-focused preventive and restorative dental services. - Related diagnostics and ancillary services: dental imaging, preventative care programs, and patient education initiatives. - Hospital network services: in-house dental hospitals and clinics offering multidisciplinary dental care, acute and elective procedures, and post-treatment follow-ups. Latest major company changes - Strategic expansion of hospital network: continued growth of private dental hospitals in Zhejiang, including newly integrated facilities and expanded service offerings across Wenzhou and neighboring cities. - Focus on operational efficiency and cost discipline: ongoing efforts to optimize care delivery, reduce overhead, and improve patient throughput across the network. - Product and service diversification: enhanced emphasis on implant dentistry and orthodontics, with expanded patient access through new clinic openings and upgraded clinical capabilities. - Public disclosure and listing-related activities: ongoing regulatory disclosures in connection with its offshore corporate structure and domestic Chinese healthcare subsidiaries, including updates to filings and corporate governance practices. Additional context - Industry and segments: healthcare services with a specialization in dentistry; private dental hospital networks; outpatient clinical services; dental implants and orthodontics. - Target markets: prepaid and insured dental care consumers, private pay patients, and corporate healthcare clients seeking dental services for employees. - Geographic operations: primarily China, with headquarters in Hong Kong; significant operations in Wenzhou (Lucheng, Yueqing, Rui’an, Longgang), Zhejiang province, and additional facilities within Zhejiang and surrounding regions. - Founding year and headquarters: founded in 2011; headquartered in Hong Kong, China. - Subsidiaries/structure: operates as a group with Chinese dental hospitals and clinics; related offshore structures and corporate entities connected to its listing and regulatory filings.